Labour dystocia and oxytocin augmentation — Rapid

Synopsis

Assess slow labour using cervical change, fetal descent and the clinical picture, and use oxytocin only when augmentation is appropriate and safely monitored.

Slow labour is assessed from the whole pattern of dilatation, descent, rotation, contractions and maternal and fetal condition.
Do not diagnose established first-stage delay from a long latent phase alone.
Suspect first-stage delay with less than 2 cm progress in four hours in a first labour, or similarly slow or slowing progress in a subsequent labour.
When delay is suspected, offer a further examination two hours later; less than 1 cm progress confirms delay in the NICE pathway.
Amniotomy may help confirmed delay with intact membranes, followed by reassessment before considering oxytocin.
Oxytocin requires obstetric assessment, consent, continuous CTG and a prescription expressed clearly in milliunits per minute.
Titrate no more often than every thirty minutes towards three to four contractions in ten minutes, reducing stimulation if contractions become too frequent.

Key red flags

Five or more contractions per ten minutes, or a sustained contraction with poor relaxation, requires reduction of uterine stimulation and reassessment.

A pathological CTG during oxytocin requires the infusion to stop and urgent obstetric review.

Persistent pain between contractions, fresh bleeding, maternal tachycardia or hypotension raises concern for rupture or another obstetric emergency.

No descent with increasing caput or moulding despite adequate contractions requires assessment for obstruction.

Headache, vomiting, confusion or seizures with a large positive fluid balance raises concern for hyponatraemia.

Investigation priorities

Repeat clinical examinationFirst step

Confirm whether progress is genuinely delayed and identify likely mechanisms.

Management branches

Suspected first-stage delayConfirm the pattern before intervention

Serial assessment suggests slow progress in established first-stage labour.

Explain the findings, provide support and effective analgesia, and consider contractions, position, descent and maternal and fetal condition.
Offer repeat examination after two hours; less than 1 cm further dilatation confirms delay in the NICE assessment sequence.
If delay is confirmed and membranes are intact, consider amniotomy after discussing its effect on labour duration, contraction pain and relevant risks.
Reassess two hours after amniotomy; no progress requires obstetric-led care and full assessment, including whether oxytocin is appropriate.
Escalate immediately if maternal or fetal concerns develop, without waiting for the planned repeat examination.

Key medicines

Oxytocin infusion for labour augmentationThe cited UK SmPC starts at 1–4 milliunits/minute, with increments of 1–2 milliunits/minute. Apply the NICE interval of at least 30 minutes between increases, targeting 3–4 contractions per ten minutes. For near-term induction or enhancement, the cited SmPC recommends a maximum rate of 20 milliunits/minute.Use a controlled intravenous infusion, never an augmentation bolus. A preparation of 5 units in 500 mL gives 10 milliunits/mL, so 1 milliunit/minute equals 6 mL/hour; other concentrations require recalculation. Stop for pathological CTG and review excessive activity, scar risk and fluid balance.

Terbutaline when augmentation causes excessive activityWhere acute tocolysis is indicated, NICE suggests terbutaline 0.25 mg by subcutaneous injection under obstetric supervision, with ongoing maternal and fetal monitoring after stopping oxytocin.Assess cardiovascular and metabolic risks and the response to treatment. A uterine relaxant is not a solution to mechanical obstruction, rupture or persistent compromise requiring operative birth.

Open full textbook →Answer 2 questions